Viewing Study NCT00143234


Ignite Creation Date: 2025-12-25 @ 2:20 AM
Ignite Modification Date: 2025-12-26 @ 12:52 AM
Study NCT ID: NCT00143234
Status: COMPLETED
Last Update Posted: 2021-01-27
First Post: 2005-08-31
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module